Peptide Romania
longevity

Epitalon

Tetrapeptide investigated for telomerase activity and pineal-axis signalling.

Dovezi
Preliminary
T½
Minutes
Categorie
longevity
Status
Investigational

Evaluarea dovezilor

Baza de dovezi

Preliminary16%

Strong: Multiple studii umane controlate cu rezultate consistente și replicate de grupuri independente de cercetare.

Moderate: Studii umane sau animale cu semnale pozitive; există variabilitate metodologică sau date conflictuale limitate.

Emerging: Cercetare timpurie, predominant preclinică, cu rezultate promițătoare. Confirmarea umană este limitată.

Preliminary: Date foarte limitate, în principal rapoarte exploratorii sau studii singulare fără replicare independentă.

Farmacologie

Mecanism de acțiune

Tetrapeptide investigated for telomerase activity and pineal-axis signalling.

T½Minutes
StatusInvestigational
Categorielongevity
DoveziPreliminary

Întrebări frecvente

Ce trebuie să știi

Tetrapeptide investigated for telomerase activity and pineal-axis signalling.
Epitalon has Preliminary evidence. Very limited data exists, primarily anecdotal reports or single exploratory studies without independent replication in peer-reviewed literature yet.
The half-life of Epitalon is Minutes. This determines dosing frequency in research protocols — shorter half-lives require more frequent administration to maintain stable concentrations in study subjects.
Epitalon is currently classified as: Investigational. Regulatory status varies by jurisdiction — always consult local regulations and a qualified medical professional before any use outside an approved clinical context.
Tetrapeptide investigated for telomerase activity and pineal-axis signalling.
Înapoi la peptide